Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr-Jun;8(2):82-102.
doi: 10.1097/CP9.0000000000000043. Epub 2023 Jul 20.

2023 Chinese expert consensus on the impact of COVID-19 on the management of cardiovascular diseases

Feng Bai  1 , Jun Pu  2 , Wenliang Che  3 , Jiyan Chen  4 , Mao Chen  5 , Wei Chen  6 , Xiaoping Chen  7 , Yundai Chen  8 , Xianwu Cheng  9 , Xiang Cheng  10 , Hongliang Cong  11 , Cuilian Dai  12 , Dali Fan  13 , Guosheng Fu  14 , Lei Gao  15 , Chuanyu Gao  16 , Wei Gao  17 , Junbo Ge  18 , Ben He  19 , Tao Hu  20 , Congxin Huang  21 , Jing Huang  22 , Yong Huo  23 , Shaobin Jia  24 , Jun Jiang  25 , Zhicheng Jing  26 , Xiangqing Kong  27 , Lang Li  28 , Yan Li  29 , Yigang Li  30 , Zhijuan Li  31 , Chun Liang  32 , Xianhe Lin  33 , Xianxia Liu  34 , Xuebo Liu  35 , Chengzhi Lu  36 , Genshan Ma  37 , Yitong Ma  38 , Wei Mao  39 , Xia Mei  40 , Zhongping Ning  41 , Jiafu Ou  42 , Shaderdin Slaj  43 , Chengxing Shen  44 , Haiming Shi  45 , Hong Shi  46 , Bei Shi  47 , Xi Su  48 , Ningling Sun  49 , Qizhu Tang  50 , Fang Wang  51 , Changqian Wang  52 , Jin Wang  53 , Yanqing Wu  54 , Yongjian Wu  55 , Yunlong Xia  56 , Dingcheng Xiang  57 , Pingxi Xiao  58 , Ping Xie  59 , Dingding Xiong  60 , Yawei Xu  3 , Jiefu Yang  61 , Lixia Yang  62 , Zaixin Yu  63 , Zuyi Yuan  64 , Haitao Yuan  65 , Guogang Zhang  66 , Heng Zhang  67 , Jian Zhang  55 , Li Zhang  68 , Ruiyan Zhang  69 , Shuning Zhang  18 , Shuyang Zhang  26 , Zheng Zhang  70 , Guoan Zhao  71 , Xianxian Zhao  72 , Jingang Zheng  73 , Haoyi Zheng  74 , Daxin Zhou  18 , Shenghua Zhou  75 , Yujie Zhou  76
Affiliations

2023 Chinese expert consensus on the impact of COVID-19 on the management of cardiovascular diseases

Feng Bai et al. Cardiol Plus. 2023 Apr-Jun.

Abstract

The primary site of infection in COVID-19 exhibit is the respiratory system, but multiple organ systems could be affected. The virus could directly invade cardiomyocytes. Alternatively, cytokine storm could lead to myocardial injury. More importantly, the management of existing cardiovascular diseases must be re-examined in COVID-19 due to, for example, interaction between antiviral agents and with a wide variety of pharmacological agents. The Branch of Cardiovascular Physicians of Chinese Medical Doctor Association organized a panel of experts in cardiovascular and related fields to discuss this important issue, and formulated the "2023 Chinese Expert Consensus on the Impact of COVID-19 on the Management of Cardiovascular Diseases." The Consensus was drafted on the basis of systematic review of existing evidence and diagnosis and treatment experience, and covers three major aspects: myocardial injury caused by COVID-10 and COVID-19 vaccine, the impact of COVID-19 on patients with cardiovascular disease, and the impact of COVID-19 on the cardiovascular system of healthy people, and rehabilitation guidance recommendations. The Consensus involves 11 core clinical issues, including incidence, pathogenesis, clinical manifestations, treatment strategies, prognosis, and rehabilitation. It is our hope that this Consensus will provide a practical guidance to cardiologists in the management of cardiovascular diseases in the new era of COVID-19 pandemic.

Keywords: COVID-19; Cardiovascular system; Diagnosis; Rehabilitation; Treatment.

PubMed Disclaimer

Conflict of interest statement

Junbo Ge is the Editor-in-Chief and Yong Huo is the Associate Editor of Cardiology Plus.

Figures

Figure 1.
Figure 1.
A Framework of the core elements in the 2023 Chinese Expert Consensus on the Impact of COVID-19 on the Management of Cardiovascular Diseases. COVID-19: coronavirus disease 2019.
Figure 2.
Figure 2.
Flow chart for the diagnosis of myocarditis associated with COVID-19. COVID-19: coronavirus disease 2019; ECG: electrocardiography; MRI: magnetic resonance imaging.
Figure 3.
Figure 3.
Clinical pathway for evaluation of PASC-CVD/PASC-CVS. CCTA: coronary computed tomography angiography; CMR: cardiac magnetic resonance; COVID-19: coronavirus disease 2019; CPET: cardiopulmonary exercise test; CRP: C-reactive protein; CT: computed tomography; cTn: cardiac troponin; ECG: electrocardiography; PASC-CVD: post-acute sequelae of COVID-19-cardiovascular disease; PASC-CVS: post-acute sequelae of COVID-19-cardiovascular syndrome; PET: positron emission tomography; RBT: regular blood test.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Lu G, Ling Y, Jiang MH, et al. . Primary assessment of the diversity of omicron sublineages and the epidemiologic features of autumn/winter 2022 COVID-19 wave in Chinese Mainland [published online ahead of print, 2023 Mar 31]. Front Med. 2022. doi:10.1007/s11684-022-0981-7. - PMC - PubMed
    1. Weintraub K. What to know about XBB.1.5, a more contagious COVID variant. USA TODAY. Available at: https://www.usatoday.com/story/news/health/2023/01/04/new-covid-variant-.... Accessed April 1, 2023.
    1. Johns Hopkins University. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). ArcGIS. Available at: https://coronavirus.jhu.edu/map.html. Accessed January 1, 2023.
    1. Hoffmann M, Kleine-Weber H, Schroeder S, et al. . SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271–280.e8. doi:10.1016/j.cell.2020.02.052. - PMC - PubMed
    1. Clerkin KJ, Fried JA, Raikhelkar J, et al. . COVID-19 and cardiovascular disease. Circulation. 2020;141:1648–1655. doi:10.1161/CIRCULATIONAHA.120.046941. - PubMed